The use of complementary and alternative medicine (CAM) therapies is becoming increasingly popular among patients with cancer; however, referrals to CAM by oncologists remain infrequent. There is limited synthesis of oncologists’ perspectives on CAM use and referral practices, despite availability of empirical studies with inconsistent findings. This scoping review aims to map the literature regarding oncologists’ attitudes, beliefs, and behaviors toward CAM, with a specific focus on factors influencing referral practices.
Methods:
We conducted a scoping literature review in accordance with the Joanna Briggs Institute guidelines. The protocol was registered with the Open Science Framework. We searched MEDLINE, EMBASE, CINAHL, AMED, PsycINFO, Web of Science, and Scopus databases from January 1, 1990, to February 2026. Eligible studies were peer-reviewed articles examining oncologists’ perspectives on CAM use for adults with cancer.
Results:
Out of 11,853 studies identified, 13 studies were included. Three domains were structured: Commonly referred CAM categories (natural products, mind-body practices, whole medical system, manipulative and body-based therapies, and creative art therapies); views of oncologists on CAM use (presuppositions about CAM integration, information sources and personal use, gender differences, role of workplace in CAM referral, self-reported spirituality and personal beliefs, and facilitators and barriers to CAM referral.
Conclusion:
While oncologists expressed willingness to integrate CAM for curable cancers, educational, evidence-related, and safety-driven barriers continued to impede their referral decisions. Future research should focus on examining the specific nature of barriers to practitioner collaboration and ways to address the gaps identified in the current evidence base.
SoerjomataramI, ParkinDM, PiñerosM, ZnaorA. Cancer statistics for the year 2020: An overview. Int J Cancer2021;149(4):778–789.
2.
SathishkumarK, ChaturvediM, DasP, et al.Cancer incidence estimates for 2022 & projection for 2025: Result from national cancer registry programme, India. Indian J Med Res2022;156(4&5):598–607; doi: 10.4103/ijmr.ijmr_1821_22
3.
TangkiatkumjaiM, BoardmanH, WalkerDM. Potential factors that influence usage of complementary and alternative medicine worldwide: A systematic review. BMC Complement Med Ther2020;20(1):363; doi: 10.1186/s12906-020-03157-2
4.
WittCM, BalneavesLG, CardosoMJ, et al.A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr2017;2017(52):lgx012; doi: 10.1093/jncimonographs/lgx012
GreenleeH, BalneavesLG, CarlsonLE, et al.; Society for Integrative Oncology. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr2014;2014(50):346–358; doi: 10.1093/jncimonographs/lgu041
7.
MaoJJ, PillaiGG, AndradeCJ, et al.Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin2022;72(2):144–164; doi: 10.3322/caac.21706
8.
LeisAM, WeeksLC, VerhoefMJ. Principles to guide integrative oncology and the development of an evidence base. Curr Oncol2008;15(Suppl 2):s83–s7; doi: 10.3747/co.v15i0.278
9.
GowinK, MuminovicM, ZickSM, et al.Integrative therapies in cancer care: An update on the guidelines. Am Soc Clin Oncol Educ Book2024;44(3):e431554; doi: 10.1200/EDBK_431554
10.
FouladbakhshJM, BalneavesL, JenuwineE. Understanding CAM natural health products: Implications of use among cancer patients and survivors. J Adv Pract Oncol2013;4(5):289–306.
11.
KnechtK, KinderD, StockertA. Biologically-based Complementary and Alternative Medicine (CAM) use in cancer patients: The good, the bad, the misunderstood. Front Nutr2019;6:196; doi: 10.3389/fnut.2019.00196
12.
SheuMT, JhanHJ, HsiehCM, et al.Efficacy of antioxidants as a Complementary and Alternative Medicine (CAM) in combination with the chemotherapeutic agent doxorubicin. Integr Cancer Ther2015;14(2):184–195; doi: 10.1177/1534735414564425
13.
ErnstE, CassilethBR. The prevalence of complementary/alternative medicine in cancer: A systematic review. Cancer1998;83(4):777–782.
14.
ChanA, NasrR, ArcosD, et al.Evaluation of integrative oncology modalities for symptom management: A MASCC/SIO global survey. BMC Complement Med Ther2025;25(1):406; doi: 10.1186/s12906-025-05157-6
15.
SalinsN, GhoshalA, HughesS, PrestonN. How views of oncologists and hematologists impacts palliative care referral: A systematic review. BMC Palliat Care2020;19(1):175; doi: 10.1186/s12904-020-00671-5
16.
Ben-AryeE, FrenkelM. Referring to complementary and alternative medicine—A possible tool for implementation. Complement Ther Med2008;16(6):325–330; doi: 10.1016/j.ctim.2008.02.008
17.
LeeRT, BarboA, LopezG, et al.National survey of US oncologists’ knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. J Clin Oncol2014;32(36):4095–4101; doi: 10.1200/JCO.2014.55.8676
18.
McCallMC, WardA, HeneghanC. Yoga in adult cancer: A pilot survey of attitudes and beliefs among oncologists. Curr Oncol2015;22(1):13–19; doi: 10.3747/co.22.2129
19.
AizuddinAN, Ahmad ZamzuriMAI, MansorJ, et al.Perception of integrating complementary and alternative medicine practice in patient’s treatment among the healthcare practitioners: A systematic review. Pan Afr Med J2022;43:19; doi: 10.11604/pamj.2022.43.19.31133
20.
YounBY, ChaJW, ChoS, et al.Perception, attitudes, knowledge of using complementary and alternative medicine for cancer patients among healthcare professionals: A mixed-methods systematic review. Cancer Med2023;12(18):19149–19162; doi: 10.1002/cam4.6499
21.
KwongMH, HoL, LiA, et al.Integrative oncology in cancer care - Implementation factors: Mixed-methods systematic review. BMJ Support Palliat Care2023;14(e1):e183–e199; doi: 10.1136/spcare-2022-004150
22.
BrummelB, van HeumenC, SmitsA, et al.Barriers to and facilitators of a healthy lifestyle for patients with gynecological cancer: A systematic review of qualitative and quantitative research. Maturitas2023;177:107801; doi: 10.1016/j.maturitas.2023.107801
23.
MinigL, Padilla-IserteP, ZorreroC. The relevance of gynecologic oncologists to provide high-quality of care to women with gynecological cancer. Front Oncol2015;5:308; doi: 10.3389/fonc.2015.00308
24.
PetersMDJ, GodfreyCM, KhalilH, et al.Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc2015;13(3):141–146; doi: 10.1097/XEB.0000000000000050
25.
TriccoAC, LillieE, ZarinW, et al.PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med2018;169(7):467–473; doi: 10.7326/M18-0850
26.
MunnZ, PetersMDJ, SternC, et al.Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol2018;18(1):143; doi: 10.1186/s12874-018-0611-x
27.
MakS, ThomasA. An introduction to scoping reviews. J Grad Med Educ2022;14(5):561–564; doi: 10.4300/JGME-D-22-00620.1
28.
PetersMDJ, MarnieC, TriccoAC, et al.Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth2020;18(10):2119–2126; doi: 10.11124/JBIES-20-00167
29.
CrocettiE, CrottiN, MontellaM, MussoM. Complementary medicine and oncologists’ attitudes: A survey in Italy. Tumori1996;82(6):539–542; doi: 10.1177/030089169608200605
30.
OuzzaniM, HammadyH, FedorowiczZ, ElmagarmidA. Rayyan—A web and mobile app for systematic reviews. Syst Rev2016;5(1):210; doi: 10.1186/s13643-016-0384-4
31.
NewellS, Sanson-FisherRW. Australian oncologists’ self-reported knowledge and attitudes about nontraditional therapies used by cancer patients. Med J Aust2000;172(3):110–113.
32.
HyodoI, EguchiK, NishinaT, et al.Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: A nationwide survey in Japan. Cancer2003;97(11):2861–2868; doi: 10.1002/cncr.11402
33.
SamanoEST, RibeiroLM, CamposAS, et al.Use of complementary and alternative medicine by Brazilian oncologists. Eur J Cancer Care (Engl)2005;14(2):143–148; doi: 10.1111/j.1365-2354.2005.00524.x
34.
RhodeJM, PatelDA, SenA, et al.Perception and use of complementary and alternative medicine among gynecologic oncology care providers. Int J Gynaecol Obstet2008;103(2):111–115; doi: 10.1016/j.ijgo.2008.06.001
35.
LeeRT, HlubockyFJ, HuJJ, et al.An international pilot study of oncology physicians’ opinions and practices on Complementary and Alternative Medicine (CAM). Integr Cancer Ther2008;7(2):70–75; doi: 10.1177/1534735408319059
36.
TanriverdiO, AydemirNF. Perspectives of medical oncologists regarding music therapy for patients with cancer in Turkey. Asian Pac J Cancer Prev2014;14(11):6537–6540.
37.
KleinE, BeckmannMW, BaderW, et al.Gynecologic oncologists’ attitudes and practices relating to integrative medicine: Results of a nationwide AGO survey. Arch Gynecol Obstet2017;296(2):295–301; doi: 10.1007/s00404-017-4420-y
38.
HaddadFG, AbbocheE, MohannaR, et al.The opinion of oncologists on the practice of hypnosis among cancer patients in Lebanon. Complement Ther Med2020;53:102534; doi: 10.1016/j.ctim.2020.102534
39.
Powers-JamesC, AlvarezA, MilburyK, et al.The influence of spirituality and religiosity on US oncologists’ personal use of and clinical practices regarding complementary and alternative medicine. Integr Cancer Ther2020;19; doi: 10.1177/1534735420945769
40.
CorinaG, ChristineH, KleinG. Oncologists’ experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis. Support Care Cancer2016;24(9):3857–3862; doi: 10.1007/s00520-016-3205-3
41.
FlahertyG, FitzgibbonJ, CantillonP. Attitudes of medical students toward the practice and teaching of integrative medicine. J Integr Med2015;13(6):412–415; doi: 10.1016/S2095-4964(15)60206-0
42.
PierantozziAM, SteelA, SeleemM. Integrating complementary and alternative medicine into medical intern teaching: Preliminary findings from an Australian hospital. Complement Ther Clin Pract2013;19(4):237–242; doi: 10.1016/j.ctcp.2013.06.002
43.
JoyceP, WardleJ, ZaslawskiC. Medical student attitudes towards Complementary and Alternative Medicine (CAM) in medical education: A critical review. J Complement Integr Med2016;13(4):333–345; doi: 10.1515/jcim-2014-0053
44.
SansgirySS, MhatreSK, ArtaniSM. Use of and attitude toward complementary and alternative medicine: Understanding the role of generational influence. Altern Ther Health Med2013;19(3):10–15.
45.
SchofieldP, DiggensJ, CharlesonC, et al.Effectively discussing complementary and alternative medicine in a conventional oncology setting: Communication recommendations for clinicians. Patient Educ Couns2010;79(2):143–151; doi: 10.1016/j.pec.2009.07.038
46.
HaussmannA, SchmidtME, IllmannML, et al.Meta-analysis of randomized controlled trials on yoga, psychosocial, and mindfulness-based interventions for cancer-related fatigue: What intervention characteristics are related to higher efficacy? Cancers (Basel)2022;14(8):2016; doi: 10.3390/cancers14082016
47.
RichardsonJ, SmithJE, McCallG, et al.Hypnosis for nausea and vomiting in cancer chemotherapy: A systematic review of the research evidence. Eur J Cancer Care (Engl)2007;16(5):402–412; doi: 10.1111/j.1365-2354.2006.00736.x
48.
CramerH, LaucheR, KloseP, et al.Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev2017;1(1):CD010802; doi: 10.1002/14651858.CD010802.pub2
49.
LoefM, WalachH. Quality of life in cancer patients treated with mistletoe: A systematic review and meta-analysis. BMC Complement Med Ther2020;20(1):227; doi: 10.1186/s12906-020-03013-3
50.
OstermannT, AppelbaumS, PoierD, et al.A systematic review and meta-analysis on the survival of cancer patients treated with a fermented Viscum album L. Extract (Iscador): An update of findings. Complement Med Res2020;27(4):260–271; doi: 10.1159/000505202
51.
National Academies of Sciences, Engineering, and Medicine. Complementary and Alternative Medicine in the United States. The National Academies Press: Washington, DC; 2005.
52.
KarimS, BennR, CarlsonLE, et al.Integrative oncology education: An emerging competency for oncology providers. Curr Oncol2021;28(1):853–862; doi: 10.3390/curroncol28010084
53.
ToledanoA, RaoS, FrenkelM, et al.Integrative oncology: An international perspective from six countries. Integr Cancer Ther2021;20:15347354211004730; doi: 10.1177/15347354211004730
54.
KornEL, AllegraCJ, FreidlinB. Clinical benefit scales and trial design: Some statistical issues. J Natl Cancer Inst2022;114(9):1222–1227; doi: 10.1093/jnci/djac099
55.
Del PaggioJC, SullivanR, SchragD, et al.Delivery of meaningful cancer care: A retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks. Lancet Oncol2017;18(7):887–894; doi: 10.1016/S1470-2045(17)30415-1
56.
RoterDL, HallJA. Why physician gender matters in shaping the physician-patient relationship. J Womens Health1998;7(9):1093–1097; doi: 10.1089/jwh.1998.7.1093
57.
Löffler-StastkaH, SeitzT, BillethS, et al.Significance of gender in the attitude towards doctor-patient communication in medical students and physicians. Wien Klin Wochenschr2016;128(17–18):663–668; doi: 10.1007/s00508-016-1054-1
58.
LimE, VardyJL, OhB, DhillonHM. Integration of complementary and alternative medicine into cancer-specific supportive care programs in Australia: A scoping study. Asia Pac J Clin Oncol2017;13(1):6–12; doi: 10.1111/ajco.12591
59.
Latte-NaorS, MaoJJ. Putting integrative oncology into practice: Concepts and approaches. J Oncol Pract2019;15(1):7–14; doi: 10.1200/JOP.18.00554
60.
LarsenA, CrudupT, HustonA, et al.Integrative oncology fellowship training in the United States: Uniting requirements and core competencies. J Cancer Educ2026;41(1):167–175; doi: 10.1007/s13187-025-02643-w
61.
MyersSP, CherasPA. The other side of the coin: Safety of complementary and alternative medicine. Med J Aust2004;181(4):222–225.
62.
TehWL, AbdinE, VaingankarJA, et al.Measuring social desirability bias in a multi-ethnic cohort sample: Its relationship with self-reported physical activity, dietary habits, and factor structure. BMC Public Health2023;23(1):415; doi: 10.1186/s12889-023-15309-3
63.
AndradeC. Sample size and its importance in research. Indian J Psychol Med2020;42(1):102–103; doi: 10.4103/IJPSYM.IJPSYM_504_19
64.
DengG, CassilethB. Complementary or alternative medicine in cancer care—Myths and realities. Nat Rev Clin Oncol2013;10(11):656–664; doi: 10.1038/nrclinonc.2013.125
65.
ChatterjeeA. Evaluating the barriers to the utilization of Complementary and Alternative Medicine (CAM) in the United States: An exploratory study. Adv Integr Med2023;10(4):167–171; doi: 10.1016/j.aimed.2023.10.002
66.
ChangKH, BrodieR, ChoongMA, et al.Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals. BMC Cancer2011;11:196; doi: 10.1186/1471-2407-11-196
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
